Patent · US Active

Conjugation methods

US9771432B2 · kind B2 · utility

12Cited by
86References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 27, 2016
Grant dateSep 26, 2017
Priority date
Expiry dateMay 27, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/24
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention describes a method of conjugating a cell binding agent such as an antibody with an effector group (e.g., a cytotoxic agent) or a reporter group (e.g., a radionuclide), whereby the reporter or effector group is first reacted with a bifunctional linker and the mixture is then used without purification for the conjugation reaction with the cell binding agent. The method described in this invention is advantageous for preparation of stably-linked conjugates of cell binding agents, such as antibodies with effector or reporter groups. This conjugation method provides in high yields conjugates of high purity and homogeneity that are without inter-chain cross-linking and inactivated linker residues.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.